170 related articles for article (PubMed ID: 35751684)
1. Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.
Kraus FBT; Topalov NE; Deuster E; Hysenaj I; Mayr D; Chelariu-Raicu A; Beyer S; Kolben T; Burges A; Mahner S; Trillsch F; Jeschke U; Czogalla B
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2501-2511. PubMed ID: 35751684
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer.
Xu M; Zhang B; Zhang M; Liu Y; Yin FL; Liu X; Zhuo SC
Oncol Lett; 2016 Apr; 11(4):2815-2819. PubMed ID: 27073557
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
Duan C; Li K; Pan X; Wei Z; Xiao L
BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
[TBL] [Abstract][Full Text] [Related]
4. Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients.
Bairi KE; Trapani D; Page CL; Saad A; Jarroudi OA; Afqir S
Cancer Treat Res Commun; 2022; 33():100625. PubMed ID: 36057142
[TBL] [Abstract][Full Text] [Related]
5. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis.
Yang J; Jin Y; Cheng S; Wang C; Zhang N; Huang S; Zhao Y; Wang Y
J Ovarian Res; 2021 Aug; 14(1):106. PubMed ID: 34404438
[TBL] [Abstract][Full Text] [Related]
8. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
11. Identification of histamine receptors in the canine gastrointestinal tract.
Sullivant A; Mackin A; Pharr T; Cooley J; Wills R; Archer T
Vet Immunol Immunopathol; 2016 Dec; 182():29-36. PubMed ID: 27863547
[TBL] [Abstract][Full Text] [Related]
12. Survival in Advanced Epithelial Ovarian Cancer Associated with Cardiovascular Comorbidities and Type 2 Diabetes Mellitus.
Slavchev S; Kornovski Y; Yordanov A; Ivanova Y; Kostov S; Slavcheva S
Curr Oncol; 2021 Sep; 28(5):3668-3682. PubMed ID: 34590605
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis.
Huang LJ; Deng XF; Chang F; Wu XL; Wu Y; Diao QZ
Medicine (Baltimore); 2018 Oct; 97(43):e12858. PubMed ID: 30412078
[TBL] [Abstract][Full Text] [Related]
14. Human skin mast cells express H2 and H4, but not H3 receptors.
Lippert U; Artuc M; Grützkau A; Babina M; Guhl S; Haase I; Blaschke V; Zachmann K; Knosalla M; Middel P; Krüger-Krasagakis S; Henz BM
J Invest Dermatol; 2004 Jul; 123(1):116-23. PubMed ID: 15191551
[TBL] [Abstract][Full Text] [Related]
15. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of histamine H
Yu C; Li L; Xia Q; Tang Y
Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():102-106. PubMed ID: 28964277
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer.
Li Y; Zhang C; Ji R; Lu H; Zhang W; Li LL; Liu R; Qian H; He A
Int J Gynecol Cancer; 2020 Jan; 30(1):74-82. PubMed ID: 31822507
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
Zhou M; Li L; Wang X; Wang C; Wang D
Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer.
Kujawa KA; Zembala-Nożyńska E; Cortez AJ; Kujawa T; Kupryjańczyk J; Lisowska KM
Cells; 2020 Jan; 9(1):. PubMed ID: 31936272
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
Pinacho-García M; Marichal-Cancino BA; Villalón CM
Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
